Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer
about
Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapyPretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patientsRatio of C-Reactive Protein to Albumin Predicts Muscle Mass in Adult Patients Undergoing Hemodialysis.The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patientsPrognostic nomogram integrated systemic inflammation score for patients with esophageal squamous cell carcinoma undergoing radical esophagectomyExploration and Validation of C-Reactive Protein/Albumin Ratio as a Novel Inflammation-Based Prognostic Marker in Nasopharyngeal Carcinoma.Pretreatment Albumin/Globulin Ratio Predicts the Prognosis for Small-Cell Lung Cancer.The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer.The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.C-reactive protein/albumin ratio as prognostic score in oral squamous cell carcinoma.Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markers.Prognostic value of the C-reactive protein/albumin ratio in patients with laryngeal squamous cell carcinoma.Platelet Distribution Width and Serum Albumin Levels for Discrimination of Thyroid Cancer From Benign Thyroid NodulesNeutrophil-to-Lymphocyte Ratio Predicts Outcome in Limited Disease Small-cell Lung Cancer.Prognostic Role of the Pretreatment C-Reactive Protein/Albumin Ratio in Solid Cancers: A Meta-Analysis.C-Reactive Protein/Albumin Ratio (CAR) as a Prognostic Factor in Patients with Non-Metastatic Nasopharyngeal Carcinoma.Cervical cancer systemic inflammation score: a novel predictor of prognosisThe prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis.The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.The C-reactive Protein/Albumin Ratio Is an independent Prognostic Factor for Overall Survival in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy.Postoperative C-reactive protein/albumin ratio as a novel predictor for short-term complications following gastrectomy of gastric cancer.Prognostic Effect of Albumin-to-Globulin Ratio in Patients with solid tumors: A Systematic Review and Meta-analysis.Prognostic value of the C-reactive protein/Albumin Ratio (CAR) in patients with operable soft tissue sarcoma.Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer.Clinicopathologic and prognostic significance of C-reactive protein/albumin ratio in patients with solid tumors: an updated systemic review and meta-analysis.Modeling the relationship between baseline lactate dehydrogenase and prognosis in patients with extensive-disease small cell lung cancer: a retrospective cohort study.Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients.C-Reactive Protein to Serum Albumin Ratio Is an Independent Predictor of All-Cause Mortality in Patients with ANCA-Associated VasculitisA novel inflammation-based nomogram system to predict survival of patients with hepatocellular carcinomaLow pre-treatment nutritional index is significantly related to poor outcomes in small cell lung cancer
P2860
Q33672758-4821A6F4-623B-4528-8575-33DFFCA8B991Q33774197-662D1C5B-89D5-4503-85C0-83EFEE2EC3F6Q36170858-E9B6DF02-62FD-4A9C-8BDA-13C2815AAEF5Q36298727-52C9337A-6B03-4BC2-A339-0BDA5DB1567DQ36392831-97F1D4BE-EE79-485E-BF54-02937A74AF93Q37133633-6478C730-1465-45A5-AB17-73AF49DEE4CEQ37205335-CE4CBCEC-6A14-4769-9323-3C3B7295BCF0Q37348288-3BA16A77-F679-4EF9-8F47-4E6D6EEB233EQ37366321-A63885FB-4E14-4F1C-9335-39796A00F53EQ37408199-E43D09F1-E135-41B5-BD74-4C8FFF0616CFQ37578830-0A82E19B-B458-4CA3-9F08-1A082C4D6712Q37652983-1DFE3B47-2B3A-4B2E-B6C2-DF295FD680A0Q38658082-4292EC90-FD1A-484C-884A-DA97530A89EFQ38982694-AC9EF302-9D10-4DC2-BDA6-C90B4ACDFBECQ38995892-AD25B0E3-F26F-47A2-B3D4-61EBD64F866AQ39314186-81247E8A-E65E-4345-B157-562A113B53D5Q39991182-FA9B2B95-F94A-4120-9B6A-6BA71CD0D822Q41016068-9F76DE70-F5BD-42FD-9979-50974D1A0C6DQ41093379-3F845F15-AFB9-43AE-A1CF-80CC1ABF75D5Q42364956-C4F3C191-05F8-4852-B530-793A89B6523CQ42634332-B440D47A-4C14-4CFD-89A2-BFF484285351Q47122678-BE6D98AD-7F12-491D-9363-9E07D9FB849CQ47140574-0A0B2727-EBFD-402D-8FCD-A01735254CFCQ47295549-786BB121-B9AB-4EC8-B73D-3FFD9BF52B89Q52641570-4F42FDAD-2045-4423-BE75-7D46AC764E0AQ55018803-F9BC44A1-2594-4D6F-8DD5-AD60A66C374EQ55315179-071C60FC-8933-4CCA-B5A6-0AE755776254Q58797488-36CF0E96-7B15-472E-AA32-B7126C8DF5F5Q59127090-3F31318B-12DE-4B78-8202-B0E31D2C83A8Q59137542-390AE9F8-513B-4B0D-B60E-73B51E5F225D
P2860
Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Ratio of C-Reactive Protein/Al ...... ts with Small-cell Lung Cancer
@ast
Ratio of C-Reactive Protein/Al ...... ts with Small-cell Lung Cancer
@en
type
label
Ratio of C-Reactive Protein/Al ...... ts with Small-cell Lung Cancer
@ast
Ratio of C-Reactive Protein/Al ...... ts with Small-cell Lung Cancer
@en
prefLabel
Ratio of C-Reactive Protein/Al ...... ts with Small-cell Lung Cancer
@ast
Ratio of C-Reactive Protein/Al ...... ts with Small-cell Lung Cancer
@en
P2093
P2860
P356
P1433
P1476
Ratio of C-Reactive Protein/Al ...... ts with Small-cell Lung Cancer
@en
P2093
Hongyun Zhao
Jianhua Zhan
Shaodong Hong
Wenfeng Fang
Yuanyuan Zhao
P2860
P2888
P356
10.1038/SREP10481
P407
P577
2015-06-18T00:00:00Z
P5875
P6179
1024785603